2hon MSN
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...
An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
More than 2 years after the child was born, no identifiable features of SMA have been observed, reported Richard Finkel, MD, of St. Jude Children's Research Hospital in Memphis, Tennessee, and ...
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results